choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • NuVasive Maximum Access Surgery

NuVasive Maximum Access Surgery Newsletter
  • NuVasive, Inc. (NUVA) CEO Chris Barry on Q1 2022 Earnings Call Transcript 05 May 2022 02:07 GMT

    … and welcome to the NuVasive First Quarter 2022 Earnings Conference … President of Investor Relations at NuVasive. Please go ahead, Ms … multiple vectors of growth. NuVasive delivered strong first quarter 2022 … Simplify, X360 and XLIF and MAS TLIF. In closing, I…

  • 32.8% Return Seen to Date on SmarTrend Nuvasive Inc Call (NUVA) 13 May 2021 07:15 GMT

    … identified an Uptrend for Nuvasive Inc (NASDAQ:NUVA) … In approximately 5 months, Nuvasive Inc has returned 32. … MA has advanced 0.6%. NuVasive, Inc. designs, develops, … 's products include maximum access surgery (MAS) and fusion products. SmarTrend …

  • Uptrend Call Working As Nuvasive Inc Stock Rises 34.1% (NUVA) 23 Mar 2021 10:35 GMT

    … SmarTrend identified an Uptrend for Nuvasive Inc (NASDAQ:NUVA) on December … over the past week, respectively. NuVasive, Inc. designs, develops, and markets … Company's products include maximum access surgery (MAS) and fusion products. SmarTrend will …

  • NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2020 Results - Earnings Call Transcript 05 Aug 2020 02:19 GMT

    … financial information on www.nuvasive.com for further information … environment. In conclusion, NuVasive experienced the most acute … collective strength and commitment, NuVasive continues to uphold our … our other MAS interventions like MAS TLIF or MAS Plus. And …

  • Nuvasive Inc Has Returned 30.7% Since SmarTrend Recommendation (NUVA) 09 Apr 2020 21:10 GMT

    … SmarTrend identified an Uptrend for Nuvasive Inc (NASDAQ:NUVA) … In approximately 2 weeks, Nuvasive Inc has returned 30. … MA has declined 2.7%. NuVasive, Inc. designs, develops, … 's products include maximum access surgery (MAS) and fusion products. SmarTrend …

  • NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity 18 Jun 2020 14:17 GMT

    … MAS, Reline Trauma and Reline Small Stature. Since its commercial launch, NuVasive … invasive surgery, NuVasive is committed to … spinal deformities." About NuVasive NuVasive, Inc. (NASDAQ: … www.nuvasive.com. Forward-Looking Statements NuVasive cautions …

  • Uptrend Call Working As Nuvasive Inc Stock Rises 15.3% (NUVA) 05 Feb 2020 20:23 GMT

    … identified an Uptrend for Nuvasive Inc (NASDAQ:NUVA) … In approximately 4 months, Nuvasive Inc has returned 15. … MA has advanced 0.4%. NuVasive, Inc. designs, develops, … 's products include maximum access surgery (MAS) and fusion products. SmarTrend …

  • NuVasive: An Attractively Priced Growth Stock 20 Aug 2019 16:56 GMT

    … minimally disruptive surgical platform called Maximum Access Surgery, or MAS, which offers spine surgeons … has further strengthened the MAS platform. NuVasive Launches Pulse Few weeks … Institute in Arizona, said: NuVasive's Pulse platform provides …

  • Uptrend Call Working As Nuvasive Inc Stock Rises 19.8% (NUVA) 14 May 2019 19:49 GMT

    … identified an Uptrend for Nuvasive Inc (NASDAQ:NUVA) … In approximately 3 months, Nuvasive Inc has returned 19. … MA has advanced 0.3%. NuVasive, Inc. designs, develops, … 's products include maximum access surgery (MAS) and fusion products. SmarTrend …

  • Nuvasive Inc Shares Down 13.9% Since SmarTrend's Sell Call (NUVA) 04 Feb 2019 19:24 GMT

    … identified a Downtrend for Nuvasive Inc (NASDAQ:NUVA) … In approximately 2 months, Nuvasive Inc has returned 13. … MA has declined 1.9%. NuVasive, Inc. designs, develops, … 's products include maximum access surgery (MAS) and fusion products. SmarTrend …

Satisfied with the content?

Continue to create your account.